Evidence map›Paper›PMID 39398428›Full record

ReviewPhenomics (Cham, Switzerland)2024

Synergistically Augmenting Cancer Immunotherapy by Physical Manipulation of Pyroptosis Induction.

Chenyang Zhao, Tingting Zheng, Run Wang, Xiaona Lin, Zhengming Hu, Zhuofei Zhao, Zhifei Dai, Desheng Sun

Abstract readReview
In one paragraph

Review in Phenomics (Cham, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chenyang ZhaoDepartment of Ultrasonography, Peking University Shenzhen Hospital, Shenzhen, 518036 Guangdong China.ORCID 0000-0001-9389-0652
Tingting ZhengDepartment of Ultrasonography, Peking University Shenzhen Hospital, Shenzhen, 518036 Guangdong China.ORCID 0000-0003-0424-0231
Run WangDepartment of Ultrasonography, Peking University Shenzhen Hospital, Shenzhen, 518036 Guangdong China.ORCID 0000-0002-0024-9047
Xiaona LinDepartment of Ultrasonography, Peking University Shenzhen Hospital, Shenzhen, 518036 Guangdong China.ORCID 0000-0002-6528-7319
Zhengming HuDepartment of Ultrasonography, Peking University Shenzhen Hospital, Shenzhen, 518036 Guangdong China.ORCID 0000-0003-3902-1506
Zhuofei ZhaoDepartment of Ultrasonography, Peking University Shenzhen Hospital, Shenzhen, 518036 Guangdong China.ORCID 0009-0003-2881-185X
Zhifei DaiDepartment of Biomedical Engineering, College of Future Technology, National Biomedical Imaging Centre, Peking University, Beijing, 100871 China.ORCID 0000-0002-8283-3190
Desheng SunDepartment of Ultrasonography, Peking University Shenzhen Hospital, Shenzhen, 518036 Guangdong China.ORCID 0000-0003-0328-1197

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyroptosis is a newly recognized type of programmed cell death mediated by the gasdermin family and caspase. It is characterized by the formation of inflammasomes and the following inflammatory responses. Recent studies have elucidated the value of pyroptosis induction in cancer treatment. The inflammatory cytokines produced during pyroptosis can trigger immune responses to suppress malignancy. Physical approaches for cancer treatment, including radiotherapy, light-based techniques (photodynamic and photothermal therapy), ultrasound-based techniques (sonodynamic therapy and focused ultrasound), and electricity-based techniques (irreversible electroporation and radiofrequency ablation), are effective in clinical application. Recent studies have reported that pyroptosis is involved in the treatment process of physical approaches. Manipulating pyroptosis using physical approaches can be utilized in combating cancer, according to recent studies. Pyroptosis-triggered immunotherapy can be combined with the original anti-tumor methods to achieve a synergistic therapy and improve the therapeutic effect. Studies have also revealed that enhancing pyroptosis may increase the sensitivity of cancer cells to some physical approaches. Herein, we present a comprehensive review of the literature focusing on the associations between pyroptosis and various physical approaches for cancer and its underlying mechanisms. We also discussed the role of pyroptosis-triggered immunotherapy in the treatment process of physical manipulation.

Indexed as

CancerCancer immunotherapyPhysical therapyProgrammed cell deathPyroptosis

Identifiers

PMID39398428
PMCPMC11466912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.